Chimeric Therapeutics Limited (CHM.AX)
AUD 0.01
(0.0%)
AUD 0.01
(0.0%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 | -0.02 AUD | 69.9% |
| 2023 | -0.06 AUD | -47.29% |
| 2022 | -0.04 AUD | 12.5% |
| 2021 | -0.05 AUD | -23100.0% |
| 2020 | -0.00 AUD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q3 | -0.01 AUD | -304.55% |
| 2024 FY | - AUD | 69.9% |
| 2024 Q2 | 0.00 AUD | 100.0% |
| 2024 Q1 | 0.00 AUD | 106.81% |
| 2024 Q4 | -0.02 AUD | -144.44% |
| 2023 Q1 | -0.01 AUD | 9.27% |
| 2023 Q2 | -0.03 AUD | -100.73% |
| 2023 Q4 | -0.03 AUD | -100.62% |
| 2023 Q3 | -0.02 AUD | 41.45% |
| 2023 FY | - AUD | -47.29% |
| 2022 Q4 | -0.02 AUD | -88.75% |
| 2022 Q3 | -0.01 AUD | 71.22% |
| 2022 Q2 | -0.03 AUD | -91.72% |
| 2022 Q1 | -0.01 AUD | 56.72% |
| 2022 FY | - AUD | 49.31% |
| 2021 Q4 | -0.03 AUD | -79.14% |
| 2021 FY | - AUD | -39950.0% |
| 2021 Q3 | -0.02 AUD | -78.1% |
| 2021 Q1 | -0.01 AUD | 0.0% |
| 2021 Q2 | -0.01 AUD | -98.11% |
| 2020 FY | - AUD | 0.0% |